A first-in-human trial has reported that transplantation of neural stem cells into patients with spinal cord injury could produce measurable improvements.
A molecule associated with myelin has been demonstrated to stimulate growth in some neural cells; this aids current research methods for treating spinal cord injuries.
An international team has utilized neuronal cells programmed from genetically identical pigs to eliminate the need for immunosuppression measures.
A preliminary study has revealed that an investigational drug may help increase protein levels in babies with spinal muscular atrophy.
A research team has identified a gene that, upon elimination, could potentially spur regeneration of axons in nerve cells severed by spinal cord injury.
For the first time, researchers have discovered that non-gene mutations could cause rare developmental disorders of the CNS.
To mark International Women’s Day, we speak to neuroscientist and science communicator Samantha Yammine about her stem cell research and passion for communicating science to a wider audience.
Ruth Wood, co-creator of the Honeycomb maze, describes how the new test overcomes the challenges of its predecessors, and how it can be utilized across the spectrum of neuroscience research.
Jeff describes how dysfunction in the glymphatic system could contribute to Alzheimer’s disease, and how our growing knowledge in this area could be harnessed to develop new disease-modifying treatments.
Discover the emerging field of biomaterials in regenerative strategies for spinal cord injury in this editorial Future Science OA.